Siga Technologies (SIGA) EBITDA Margin Growth (3y) (2013 - 2025)
Powered by 
Analysis
Siga Technologies (SIGA) EBITDA Margin Growth (3y) (2013 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | 120.00 |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | 531.00 |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | 3,082.00 |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | 842.00 |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | 214.00 |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | -963.00 |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | - |
| 8 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | 2,139.00 |
| 9 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn | -1,031.00 |
| 10 | Siga Technologies | 235.60 Mn | 80.63 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -44,955.00 |
| Jun 30, 2025 | 3,789.00 |
| Mar 31, 2025 | -1,838.00 |
| Dec 31, 2024 | -1,144.00 |
| Sep 30, 2024 | 6,616.00 |
| Jun 30, 2024 | 494.00 |
| Mar 31, 2024 | 8,567.00 |
| Dec 31, 2023 | 766.00 |
| Sep 30, 2023 | -8,850.00 |
| Jun 30, 2023 | -15,028.00 |
| Mar 31, 2023 | 12,728.00 |
| Dec 31, 2022 | 6,549.00 |
| Sep 30, 2022 | 5,123.00 |
| Jun 30, 2022 | 6,206.00 |
| Mar 31, 2022 | -3,461.00 |
| Dec 31, 2021 | 43,466.00 |
| Sep 30, 2021 | -13,905.00 |
| Jun 30, 2021 | 13,943.00 |
| Mar 31, 2021 | 21,811.00 |
| Dec 31, 2020 | 41,601.00 |